A recent study reveals that a single 45-minute workout, whether resistance training or HIIT, can trigger the release of ...

In the ongoing Phase 2/3 study of tovecimig (DLL4 x VEGF-A bispecific antibody) in patients with advanced biliary tract cancer, fewer deaths have been observed than originally projected. We believe ...

This report details how pleomorphic breast carcinoma evaded initial treatment protocols and spread to 70% of the thorax within months.

One teacher in Wausau is making sure that the impact continues for one of his colleagues who passed away from cancer last ...

Agenus Inc. ("Agenus" or the "Company") (Nasdaq: AGEN), an immuno-oncology company focused on innovation, today reports ...

Researchers typically ask why people get cancer. What if they studied why some survive — or never develop the disease?

Detailed price information for Aim Immunotech Inc (AIM-A) from The Globe and Mail including charting and trades.